Sun Pharmaceutical posts higher-than-forecast Q2 profit
Sun Pharmaceutical Industries disclosed a notable upsurge in its profit for the second quarter, surpassing analyst expectations with a robust […]
Tags: Sun Pharmaceutical
Sun Pharmaceutical Industries enter licensing agreement with Philogen for skin cancer treatment
Sun Pharmaceutical Industries, announced on Tuesday that it has entered into a licensing pact with Philogen SpA, a Swiss-Italian firm, […]
Sun Pharma to acquire majority stake in Russia’s Biosintez
Indian drug major Sun Pharma has announced acquisition of 85.1 per cent stake in Russia-based JSC Biosintez for $24 million […]
Sun Pharma, govt agencies join hands on malaria project in Madhya Pradesh
Indian multinational pharmaceutical major Sun Pharma has signed a tripartite agreement with the Indian Council of Medical Research (ICMR), Government […]
Sun Pharma to Acquire InSite Vision
Sun Pharma has announced its one of the subsidiary entering into an agreement and plan of merger with InSite Vision […]
Sun Pharma hits record high
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent. Sun Pharma stock surged 2 percent […]
Wockhardt jumps on US FDA nod for generic drug
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
